BRITZILAM 25MG TABLET 14'S
By TORRENT PHARMACEUTICALS LIMITED
Contains: BRIVARACETAM 25 MG
Product Summary
| Offer Price | ₹ 137.06 |
|---|---|
| Your Savings | ₹ 24.19 (15% on MRP) |
About BRITZILAM 25MG TABLET 14'S
- BRITZILAM 25MG TABLET 14'S is a pharmaceutical compound that belongs to the class of antiepileptic drugs (AEDs). It was developed as a novel treatment option for patients suffering from epilepsy, a neurological disorder characterized by recurring seizures. BRITZILAM 25MG TABLET 14'S is primarily used as an adjunctive therapy in the management of focal (partial-onset) seizures in adults.
- The discovery and development of BRITZILAM 25MG TABLET 14'S were driven by the need for improved treatment options for epilepsy patients who experienced inadequate seizure control or intolerable side effects with existing medications. It was specifically designed to target and modulate synaptic vesicle protein 2A (SV2A), a protein involved in the regulation of neurotransmitter release in the brain. By binding to SV2A, BRITZILAM 25MG TABLET 14'S exerts its antiepileptic effects, although the exact mechanism of action is still under investigation.
- BRITZILAM 25MG TABLET 14'S has shown promising results in clinical trials, demonstrating its efficacy and tolerability in reducing the frequency and severity of seizures. It has been approved by regulatory authorities in several countries, including the United States and European Union, for the adjunctive treatment of focal seizures in adults.
- As with any medication, BRITZILAM 25MG TABLET 14'S may cause side effects, and its use should be closely monitored by healthcare professionals. Common side effects reported include somnolence, dizziness, and fatigue. It is important for patients to follow their healthcare provider's instructions regarding dosage and any necessary precautions while taking BRITZILAM 25MG TABLET 14'S.
- In conclusion, BRITZILAM 25MG TABLET 14'S represents an important advancement in the field of epilepsy treatment, providing an additional option for patients who require adjunctive therapy for focal seizures. Its unique mechanism of action and favorable clinical profile make it a valuable addition to the armamentarium of antiepileptic drugs, offering hope for improved seizure control and quality of life for individuals living with epilepsy.
Uses of BRITZILAM 25MG TABLET 14'S
- Helps in epilepsy.
- Is used in partial-onset seizures.
- Helps in focal seizures.
- Used in adults.
- Helps in children.
- Used in generalized seizures.
- Helps in adjunctive therapy.
- Used in epilepsy treatment.
How BRITZILAM 25MG TABLET 14'S Works
- BRITZILAM 25MG TABLET 14'S modulates neuronal voltage-gated sodium channels, reducing their activity and stabilizing the hyperexcitable brain cells that cause seizures.
- BRITZILAM 25MG TABLET 14'S is an antiepileptic drug that exerts its pharmacological effects by selectively binding to the synaptic vesicle protein 2A (SV2A) in the brain. SV2A is involved in regulating synaptic vesicle exocytosis, which is crucial for neurotransmitter release in the central nervous system. By binding to SV2A, BRITZILAM 25MG TABLET 14'S modulates the release of various neurotransmitters, including gamma-aminobutyric acid (GABA), glutamate, and NOREPINEPHRINE. This modulation reduces the excessive neuronal excitability and hyperactivity that lead to seizures. BRITZILAM 25MG TABLET 14'S's specific mechanism of action is not fully understood, but it is believed to enhance GABAergic inhibition and inhibit the release of excitatory neurotransmitters, thereby dampening abnormal electrical activity in the brain. This mode of action differentiates BRITZILAM 25MG TABLET 14'S from other antiepileptic drugs and contributes to its efficacy in treating epilepsy and reducing seizure frequency.
Dosage of BRITZILAM 25MG TABLET 14'S Works
- For children: The dosage of BRITZILAM 25MG TABLET 14'S for children is determined based on their body weight. It is typically prescribed by a healthcare professional specializing in pediatric epilepsy treatment.
- For adults: The usual starting dose for adults is 50 mg twice daily. The dosage may be adjusted by a healthcare professional based on individual response and tolerability, up to a maximum recommended dose of 200 mg twice daily.
Side Effects Of BRITZILAM 25MG TABLET 14'S
- Dizziness
- Fatigue
- Headache
- Nausea
- Insomnia
- Mood changes
How to Store BRITZILAM 25MG TABLET 14'S
- Store at room temperature.
- Keep away from moisture.
- Protect from light.
Frequently asked questions about BRITZILAM 25MG TABLET 14'S
No, BRITZILAM 25MG TABLET 14'S is approved as an adjunctive therapy, meaning it is used in combination with other antiepileptic drugs.
The onset of action of BRITZILAM 25MG TABLET 14'S varies, but it typically begins working within a few days to weeks.
There is a potential risk of birth defects. It is important to discuss the risks and benefits with a healthcare professional if planning pregnancy or already pregnant.
BRITZILAM 25MG TABLET 14'S dosage adjustments may be necessary in patients with moderate to severe liver impairment. Consult a healthcare professional for appropriate dosing guidance.
Take the missed dose as soon as you remember. If it is close to the next scheduled dose, skip the missed dose and continue with the regular dosing schedule.
Yes, BRITZILAM 25MG TABLET 14'S can interact with certain medications. Inform your healthcare professional about all the medications, including over-the-counter drugs and herbal supplements, you are taking.
Yes, mood changes and behavioral issues, such as aggression and irritability, have been reported as potential side effects of BRITZILAM 25MG TABLET 14'S. Contact a healthcare professional if any concerning symptoms occur.
Abruptly stopping BRITZILAM 25MG TABLET 14'S can lead to increased seizure frequency or other withdrawal symptoms. The dosage should be gradually reduced under the guidance of a healthcare professional.
References related to BRITZILAM 25MG TABLET 14'S
- Brivaracetam. (2021, June 21). Retrieved June 1, 2023, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK500879/
Neha Pathak
Reviewed on 10 Feb 2024
Neha Pathak
Reviewed on 10 Feb 2024
Can get the medicines here on pocket friendly rates !
Pallav Bhatt
Reviewed on 22 Nov 2022
Pallav Bhatt
Reviewed on 22 Nov 2022
Good service. Public relations are very good.
Saurav
Reviewed on 11 Jan 2024
Saurav
Reviewed on 11 Jan 2024
Genuine product....
Ashutosh Buch
Reviewed on 24 Feb 2023
Ashutosh Buch
Reviewed on 24 Feb 2023
Nice experience, always!
Binal Doshi
Reviewed on 03 Jan 2023
Binal Doshi
Reviewed on 03 Jan 2023
Very good and quik responce for all medicines